4-aminoquinoline compounds
CA 2468159 A1 · Owner: Sailer, Andreas W. · Inventors: Sailer, Andreas W.; Hoang, Myle Thi; Jiang, Jinlong
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is concerned with compounds of the general Formula I : and pharmaceutically acceptable salts thereof which are useful as melanin , concentrating hormone receptor antagonists particularly MCH-1R antagonists. , As such compounds of the present invention are useful for the treatment or prevention of obesity or eating disorders associated with excessive food intake and complications thereof, osteoarthritis certain cancers, AIDS , wasting, cachexia frailty (particularly in elderly), mental disorders stress cognitive disorders, sexual function, reproductive function kidney function, locomotor disorders, attention deficit disorder (ADD) substance abuse , disorders and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 22, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.